Study guide
18.3 Seronegative Spondyloarthropathies
MRCP UK
Track your progress as you read
Finished sections get a check mark.
1 MRCP(UK) Part 1: Exam Overview, Blueprint & Strategy
1.1 Part 1 Format, Delivery and Fees 1.2 The Official Blueprint and Mark Allocation 1.3 Scaled Scoring, Attempt Limits and Best-of-Five Technique
2 Clinical Sciences: Cellular, Genetic & Molecular Medicine
2.1 Organelles, Cytoskeleton & Membrane Transport 2.2 Cell Cycle Control, Apoptosis & Cell Signalling 2.3 Mendelian & Non-Mendelian Inheritance 2.4 Trinucleotide Repeat Disorders & Chromosomal Abnormalities 2.5 Purine, Pyrimidine Metabolism & the Porphyrias 2.6 Glycogen, Lipid Storage & Amino Acid Disorders
3 Clinical Sciences: Anatomy, Physiology & Immunology
3.1 Clinical & Cross-Sectional Anatomy 3.2 Systemic Clinical Physiology & Homeostasis 3.3 Clinical Immunology & Hypersensitivity Reactions
4 Clinical Sciences: Statistics, Epidemiology & Trial Design
4.1 Study Designs & Evidence Hierarchy 4.2 Diagnostic Testing, Screening & Predictive Values 4.3 Statistical Analysis & Risk Quantification
5 Clinical Pharmacology, Therapeutics & Toxicology
5.1 Pharmacokinetics & Pharmacodynamics 5.2 Cytochrome P450 Systems & High-Risk Drug Interactions 5.3 Adverse Drug Reactions & Therapeutic Drug Monitoring 5.4 Paracetamol & Salicylate Poisoning 5.5 Toxidromes, Antidotes, Carbon Monoxide & Toxic Alcohols
6 Cardiology: Coronary Artery Disease & Heart Failure
6.1 Acute Coronary Syndromes & Myocardial Infarction 6.2 Heart Failure & Cardiomyopathies 6.3 Cardiac Assessment & ECG Interpretation
7 Cardiology: Arrhythmias, Valvular & Pericardial Disease
7.1 Atrial Fibrillation, Narrow & Broad Complex Tachycardias 7.2 Bradyarrhythmias, Conduction Block & Antiarrhythmic Drugs 7.3 Valvular Heart Disease & Murmur Interpretation 7.4 Infective Endocarditis 7.5 Pericardial & Acute Aortic Diseases
8 Respiratory Medicine: Airway & Parenchymal Lung Disease
8.1 Asthma: Diagnosis, Chronic Management & Acute Attacks 8.2 COPD: GOLD Staging, Stable Management, Exacerbations & NIV 8.3 Interstitial Lung Disease & Sarcoidosis 8.4 Respiratory Infections & Bronchiectasis
9 Respiratory Medicine: Vascular, Pleural & Sleep Disorders
9.1 Venous Thromboembolism & Pulmonary Embolism 9.2 Pleural Effusion & Pneumothorax 9.3 Respiratory Failure & Sleep-Disordered Breathing
10 Gastroenterology: Luminal Gastrointestinal Disease
10.1 GORD, Barrett's Oesophagus & Oesophageal Motility Disorders 10.2 Peptic Ulcer Disease, Helicobacter pylori & Zollinger-Ellison Syndrome 10.3 Crohn's Disease, Ulcerative Colitis & Extraintestinal Manifestations 10.4 IBD Medical Therapy, Coeliac Disease & Malabsorption 10.5 Acute Upper Gastrointestinal Bleeding: Risk Scores, Ulcer & Variceal Haemorrhage 10.6 Lower Gastrointestinal Disorders & Colonic Neoplasia
11 Gastroenterology: Liver, Biliary & Pancreatic Disease
11.1 Viral Hepatitis A to E 11.2 Autoimmune Hepatitis & Metabolic Liver Disease 11.3 Cirrhosis & Complications of Portal Hypertension 11.4 Cholestatic Liver Disease: PBC and PSC 11.5 Gallstone Disease, Biliary Sepsis & Pancreatitis
12 Endocrinology & Diabetes: Diabetes & Thyroid
12.1 Diabetes: Diagnostic Thresholds, Classification & Pathophysiology 12.2 NICE-Directed Type 2 Therapy & Microvascular Complications 12.3 Acute Diabetic Emergencies (DKA & HHS) 12.4 Thyrotoxicosis, Thyroiditis & Management of Hyperthyroidism 12.5 Hypothyroidism, Subclinical Disease & Thyroid Nodules
13 Endocrinology & Diabetes: Adrenal, Pituitary & Calcium
13.1 Hypopituitarism, Pituitary Apoplexy & Hyperprolactinaemia 13.2 Acromegaly, Diabetes Insipidus & SIADH 13.3 Cushing's Syndrome: Aetiology, Screening & Localisation 13.4 Adrenal Insufficiency & Endocrine Hypertension 13.5 Calcium Regulation & Hypercalcaemia 13.6 Hypocalcaemia & Metabolic Bone Disease
14 Renal Medicine: AKI, Glomerular & Tubulointerstitial Disease
14.1 Acute Kidney Injury & Chronic Kidney Disease 14.2 Nephrotic and Nephritic Syndromes & Primary Glomerular Disease 14.3 Rapidly Progressive Glomerulonephritis 14.4 Tubulointerstitial & Inherited Renal Diseases
15 Renal Medicine: Fluid, Electrolytes & Acid-Base Balance
15.1 Sodium & Water Disorders 15.2 Potassium, Magnesium & Phosphate Disorders 15.3 Acid-Base Disorders & Blood Gas Analysis
16 Neurology: Cerebrovascular, Headache & Demyelinating Disease
16.1 Stroke Classification, Brainstem Syndromes & Hyperacute Reperfusion 16.2 Secondary Prevention, TIA, Carotid Surgery & Intracranial Haemorrhage 16.3 Headache Disorders & Cranial Neuralgias 16.4 Multiple Sclerosis & Central Demyelinating Diseases
17 Neurology: Epilepsy, Movement Disorders & Neuromuscular Disease
17.1 Epilepsy & Acute Seizures 17.2 Movement Disorders & Cognitive Impairment 17.3 Neuromuscular Junction & Peripheral Nerve Disorders
18 Rheumatology: Inflammatory Arthritis & Connective Tissue Disease
18.1 Rheumatoid Arthritis: Pathophysiology, Clinical Features & Diagnosis 18.2 DMARDs, Biologics & Their Toxicities 18.3 Seronegative Spondyloarthropathies 18.4 Systemic Lupus Erythematosus & Drug-Induced Lupus 18.5 Systemic Sclerosis & Scleroderma Renal Crisis 18.6 Sjogren's Syndrome & Inflammatory Myopathies
19 Rheumatology: Systemic Vasculitis & Crystal Arthropathy
19.1 Vasculitis Classification, Large and Medium Vessel Disease 19.2 ANCA-Associated and Immune Complex Small Vessel Vasculitis 19.3 Gout & Calcium Pyrophosphate Deposition Disease
20 Infectious Diseases & Tropical Medicine
20.1 Sepsis-3 Definitions & the Sepsis Six 20.2 Bacterial Meningitis, CSF Interpretation & Toxic Shock Syndrome 20.3 Tuberculosis: Pathogenesis & Clinical Manifestations 20.4 Tuberculosis: Diagnosis & Anti-Tuberculous Therapy 20.5 HIV Infection & Opportunistic Diseases 20.6 Malaria: Species, Life Cycle & Severe Disease 20.7 Enteric Fever, Arboviral Infection & Tissue Parasites
21 Haematology: Anaemias & Red Cell Disorders
21.1 MCV-Based Diagnostic Approach to Anaemia 21.2 Haemolytic and Autoimmune Haemolytic Anaemias 21.3 Membranopathies, Enzymopathies, PNH & Sickle Cell Disease
22 Haematology: Malignancy, Coagulation & Transfusion Medicine
22.1 Acute Leukaemias 22.2 Chronic Leukaemias & Myeloproliferative Neoplasms 22.3 Lymphomas & Plasma Cell Dyscrasias 22.4 Coagulation Cascade & Inherited Bleeding Disorders 22.5 Thrombocytopenia & Thrombotic Microangiopathies 22.6 Transfusion Products & Acute Transfusion Reactions
23 Psychiatry in General Medicine
23.1 Mood & Psychotic Disorders in Medical Patients 23.2 Psychiatric Emergencies & Substance Misuse 23.3 Mental Capacity & UK Mental Health Law
24 Geriatric Medicine
24.1 Comprehensive Geriatric Assessment, Frailty, Delirium & Falls 24.2 Polypharmacy, Deprescribing & Pressure Ulcers
25 Dermatology
25.1 Inflammatory Skin Disease, Immunobullous Disorders & Severe Drug Eruptions 25.2 Cutaneous Malignancy
26 Oncology & Palliative Medicine
26.1 Neutropenic Sepsis, Spinal Cord Compression & SVC Obstruction 26.2 Hypercalcaemia of Malignancy & Tumour Lysis Syndrome 26.3 Palliative Care & End-of-Life Symptom Control
27 Medical Ophthalmology
27.1 The Acute Red Eye & Sudden Painless Visual Loss 27.2 Retinopathy in Systemic Disease
18.3 Seronegative Spondyloarthropathies
Key Takeaways Explain This Topic AI
Ankylosing spondylitis causes inflammatory back pain improving with exercise, bilateral sacroiliitis and a bamboo spine, and is treated with NSAIDs, physiotherapy and TNF inhibitors if refractory.
Reactive arthritis follows gastrointestinal or genitourinary infection by 1-4 weeks and may include conjunctivitis, urethritis, keratoderma blennorrhagicum and circinate balanitis.
Psoriatic arthritis includes a distal interphalangeal pattern with nail dystrophy and arthritis mutilans, with the pencil-in-cup radiographic appearance.
Last updated: September 2026
6. Seronegative Spondyloarthropathies: Overview & Axial SpA
The seronegative spondyloarthropathies (SpA) are a clinically and genetically interrelated family of chronic inflammatory arthritides characterized by: (1) Absence of RF and anti-CCP; (2) Strong genetic association with HLA-B27 ; (3) Pathognomonic enthesitis (inflammation at sites of tendon, ligament, or joint capsule insertion into cortical bone); (4) Dactylitis ("sausage digits"); and (5) Axial spinal inflammation and/or asymmetrical peripheral oligoarthritis.
Ankylosing Spondylitis (Axial Spondyloarthritis)
Axial SpA is a chronic inflammatory disorder predominantly affecting the sacroiliac joints and axial skeleton, with a male predilection (2:1 to 3:1) and peak onset between 20 and 30 years. Axial SpA Diagnostic & Radiographic Spectrum
- |
- +-----------------------------------+-----------------------------------+
- | |
- 1. Early / Non-Radiographic Axial SpA 2. Established Ankylosing Spondylitis
- Normal plain pelvic radiographs - Bilateral sacroiliitis on plain X-ray
- MRI (STIR): Bone marrow oedema - Vertebral squaring ('shiny corners')
- and active subchondral sacroiliitis - Thin, vertical syndesmophytes
- HLA-B27 positive in > 90% - Complete fusion ('bamboo spine')
Clinical Presentation: Characterized by inflammatory back pain (IBP) , which must be clearly differentiated from common mechanical low back pain:
- Clinical Parameter Inflammatory Back Pain (SpA) Mechanical Back Pain (Lumbar Spondylosis, Disc)
- Age of Onset Typically < 45 years (often 20–35) Any age; commonly > 40 years
- Onset Insidious, gradual (months) Acute or subacute; often post-exertional
- Morning Stiffness Prolonged (> 30–60 minutes) Brief (< 15–30 minutes)
Diurnal Pattern Worse in morning and second half of night (waking patient) Worse in evening and after daily physical activity
Effect of Exercise Improves with exercise/movement ; no relief with rest Worsens with exercise; relieved by rest
NSAID Response Rapid, marked relief within 24–48 hours Modest or incomplete relief
Clinical Examination Signs:
Modified Schober's Test: Assesses loss of lumbar spine flexion. With the patient standing erect, a mark is made at the lumbosacral junction (level of dimples of Venus / L5 spinous process); a second mark is placed 10 cm superiorly, and a third mark 5 cm inferiorly (total 15 cm distance). The patient bends forward maximally with straight knees. Normal expansion is >= 5 cm (total distance >= 20 cm). Expansion < 5 cm indicates restricted lumbar flexion diagnostic of lumbar spinal ankylosis.
Occiput-to-Wall Distance: In advanced disease, loss of lumbar lordosis, accentuation of thoracic kyphosis, and fixed cervical flexion prevent the occiput from touching a vertical wall while standing with heels and buttocks against it.
Reduced Chest Expansion: Costovertebral and costosternal joint ankylosis restricts rib cage excursion. Chest expansion measured at the 4th intercostal space < 2.5 cm is abnormal.
Imaging Hallmarks:
MRI of Sacroiliac Joints (STIR sequence): The diagnostic gold standard for early, non-radiographic axial SpA before irreversible bony changes develop. Demonstrates subchondral bone marrow oedema (active sacroiliitis) reflecting intense osteitis.
Pelvic Radiographs: Demonstrates bilateral, symmetrical sacroiliitis: subchondral sclerosis, joint margin blurring, erosions, and eventual complete bony fusion.
Spine Radiographs: Sclerosis of anterior vertebral margins producing "shiny corners" (Romanus lesions) , followed by vertebral body squaring. Calcification and ossification of the outer fibres of the annulus fibrosus form delicate, thin, vertically oriented bony bridges termed syndesmophytes . Symmetrical syndesmophytes bridging successive vertebrae alongside ossification of interspinous ligaments (the "dagger sign") produce the classical "bamboo spine" . Prone to low-impact transverse spinal fractures (commonly lower cervical spine) that cause catastrophic spinal cord injury.
Extra-Skeletal Manifestations:
Acute Anterior Uveitis (Iritis): The most common extra-skeletal feature (occurs in 25–30% of patients). Characteristically unilateral, presenting with acute eye pain, photophobia, ciliary injection, and blurred vision. Managed with topical corticosteroid and mydriatic drops.
Cardiovascular: Ascending aortitis causing fibrous thickening and dilation of the aortic root, producing aortic regurgitation . Fibrosis extending into the membranous interventricular septum causes atrioventricular nodal conduction blocks (PR prolongation, complete heart block).
Pulmonary: Upper lobe fibrocavitary disease ( apical pulmonary fibrosis ), often bilateral; cavitating fibrotic bullae can become colonized by Aspergillus fumigatus , forming aspergillomas (fungus balls).
Neurological: Cauda equina syndrome secondary to chronic lumbosacral dural ectasia.
Therapeutic Strategy:
Non-Pharmacological (Cornerstone): Daily spinal extension exercises and specialized physiotherapy are mandatory to maintain posture and chest expansion.
First-Line Pharmacotherapy: Continuous, full-dose NSAIDs (e.g. naproxen, celecoxib) provide symptomatic relief and may retard syndesmophyte formation.
Second-Line Biologics: Patients with persistent active axial disease despite two different NSAIDs are escalated directly to anti-TNF therapy (e.g. adalimumab, etanercept) or anti-IL-17A inhibitors (secukinumab, ixekizumab) .
CRUCIAL EXAM FACT: Conventional csDMARDs (methotrexate, sulfasalazine) are ineffective for axial spine disease and sacroiliitis ; their utility is strictly limited to managing concurrent peripheral arthritis.
- 7. Psoriatic, Reactive & Enteropathic Arthritis
- Psoriatic Arthritis (PsA)
An inflammatory arthritis developing in 20–30% of patients with cutaneous psoriasis; skin lesions precede joint symptoms by years in 70%, but arthritis appears concurrently or preceding rash in 15–20%.
Clinical Phenotypes (Moll & Wright Classification):
Asymmetrical Oligoarthritis (< 5 joints): Historically most common; affects knees, ankles, and small digits.
Symmetrical Polyarthritis: Symmetrical involvement of MCP and PIP joints, mimicking rheumatoid arthritis, but RF and anti-CCP negative.
Distal Interphalangeal (DIP) Predominant: Classic form; DIP joint involvement tightly coupled with overlying psoriatic nail disease.
Axial Spondylitis / Sacroiliitis: Unilateral or asymmetrical sacroiliitis with bulky, coarse, asymmetrical non-marginal syndesmophytes (paramarginal calcifications), distinct from the delicate syndesmophytes of AS.
Arthritis Mutilans: Severe, destructive, osteolytic resorption of phalanges and metacarpals, resulting in telescoping of fingers ( "telescoping digits" / opera-glass hand / main en lorgnette ).
Key Features: Dactylitis ("sausage digit" from simultaneous flexor tenosynovitis and joint synovitis) and psoriatic nail dystrophy (present in > 80% of PsA vs 30% of uncomplicated psoriasis: nail pitting [> 20 pits], onycholysis, subungual hyperkeratosis, and "oil drop" / salmon patch discoloration).
Radiography: Pathognomonic "pencil-in-cup" deformity —marked periarticular bone erosion producing tapering/sharpening of the proximal phalanx head ("pencil") which projects into an expanded, excavated socket of the adjacent distal phalanx base ("cup"). Displays periostitis (fluffy new bone formation) and absence of periarticular osteopenia (unlike RA).
Reactive Arthritis (ReA)
An acute, sterile autoimmune synovitis that develops 1 to 4 weeks following an antecedent gastrointestinal or genitourinary mucosal infection.
Triggering Pathogens:
Gastrointestinal / Enteric: Campylobacter jejuni , Salmonella enteritidis/typhimurium , Shigella flexneri , Yersinia enterocolitica , and Clostridioides difficile .
Genitourinary: Chlamydia trachomatis (predominant GU trigger) and Ureaplasma urealyticum .
Clinical Presentation: Asymmetrical, acute, inflammatory oligoarthritis predominantly involving large weight-bearing lower limb joints (knee, ankle, subtalar). Strongly associated with Achilles enthesitis, plantar fasciitis, and dactylitis.
The Classical Triad: Historically known as Reiter's syndrome: Arthritis , non-gonococcal urethritis / cervicitis , and conjunctivitis (sterile, bilateral).
Distinctive Mucocutaneous Lesions:
Circinate Balanitis: Painless, superficial, serpiginous, erythematous erosions with raised white borders on the glans penis and coronal sulcus (occurs in up to 40% of men).
Keratoderma Blennorrhagica: Hyperkeratotic, waxy, brownish-red papules and plaques on the soles of the feet and palms of the hands; clinically and histologically indistinguishable from pustular psoriasis.
Painless Superficial Oral Ulcers: Palatal and buccal mucosal erosions.
Management: Active Chlamydia infection must be treated with oral antibiotics (e.g. doxycycline) for both the patient and sexual partners to clear mucosal carriage, but antibiotics do not alter or accelerate resolution of the established reactive arthritis . Acute arthritis is treated with NSAIDs and intra-articular corticosteroid injections. Chronic, persistent cases (> 3 months) respond to sulfasalazine or methotrexate.
Enteropathic Arthritis
Inflammatory arthritis complicating Inflammatory Bowel Disease (IBD) —Crohn's disease and Ulcerative Colitis.
Type 1 (Pauciarticular): Involves < 5 joints, predominantly large lower-limb joints (knees, ankles). Parallels bowel disease activity ; flares coincide with intestinal relapses. Effectively treated by medically or surgically controlling the underlying bowel inflammation.
Type 2 (Polyarticular): Involves >= 5 joints, predominantly small joints of the hands symmetrically. Independent of bowel disease activity ; runs a persistent, chronic course uncoupled from luminal inflammation.
Axial Spondylarthritis in IBD: Manifests as sacroiliitis and spondylitis. Associated with HLA-B27 in 50–70% of cases. Its progression is completely independent of bowel disease activity . NSAIDs must be used with extreme caution as they can trigger severe relapses of mucosal IBD; anti-TNF agents (infliximab, adalimumab) provide dual efficacy for both bowel and joint pathology.
8. Comparative Synthesis: RA vs. Spondyloarthropathies vs. Gout
Diagnostic Domain Rheumatoid Arthritis (RA) Spondyloarthropathies (SpA) Gouty Arthritis
Primary Pathology Synovial pannus proliferation; invasive osteoclastic erosion Enthesitis (tendon-bone junction); subchondral osteitis Monosodium urate crystal phagocytosis; NLPR3 inflammasome
Symmetry & Distribution Symmetrical polyarthritis ; MCP, PIP, MTP, wrists; spares DIPs Asymmetrical oligoarthritis (lower limbs) or axial spine Asymmetric monoarthritis ; 1st MTP (podagra), midfoot, knee
Axial Spine Involvement C1–C2 atlantoaxial subluxation only ; spares thoracolumbar Sacroiliitis and spondylitis throughout lumbar/thoracic Exceptional; rare axial tophaceous deposits
Genetic Associations HLA-DR4 / HLA-DRB1 shared epitope HLA-B27 (strongest in AS >90%) Complex polygenic; URAT1/SLC2A9 transporters
Serological Markers Anti-CCP (>95% spec), Rheumatoid Factor (75% sens) Seronegative (RF and anti-CCP negative) Hyperuricaemia (urate > 400 µmol/L; may be normal in flare)
Characteristic Signs Boutonniere, swan-neck, ulnar drift, subcutaneous nodules Dactylitis ('sausage digit'), enthesitis, uveitis, balanitis Tophi (ear helix, olecranon), intense periarticular erythema
Radiographic Features Periarticular osteopenia, marginal erosions, uniform joint narrowing Syndesmophytes ('bamboo spine'), pencil-in-cup, periostitis Punched-out "rat-bite" erosions with overhanging edges
Synovial Fluid Findings Inflammatory; high neutrophils; low glucose; no crystals Inflammatory; high neutrophils; sterile; no crystals Needle-shaped, strongly negatively birefringent crystals